Potential Use of a Combined Bacteriophage-Probiotic Sanitation System to Control Microbial Contamination and AMR in Healthcare Settings: A Pre-Post Intervention Study.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Mar 2023
Historique:
received: 06 03 2023
revised: 24 03 2023
accepted: 26 03 2023
medline: 14 4 2023
entrez: 13 4 2023
pubmed: 14 4 2023
Statut: epublish

Résumé

Microbial contamination in the hospital environment is a major concern for public health, since it significantly contributes to the onset of healthcare-associated infections (HAIs), which are further complicated by the alarming level of antimicrobial resistance (AMR) of HAI-associated pathogens. Chemical disinfection to control bioburden has a temporary effect and can favor the selection of resistant pathogens, as observed during the COVID-19 pandemic. Instead, probiotic-based sanitation (probiotic cleaning hygiene system, PCHS) was reported to stably abate pathogens, AMR, and HAIs. PCHS action is not rapid nor specific, being based on competitive exclusion, but the addition of lytic bacteriophages that quickly and specifically kill selected bacteria was shown to improve PCHS effectiveness. This study aimed to investigate the effect of such combined probiotic-phage sanitation (PCHSφ) in two Italian hospitals, targeting staphylococcal contamination. The results showed that PCHSφ could provide a significantly higher removal of staphylococci, including resistant strains, compared with disinfectants (-76%,

Identifiants

pubmed: 37047510
pii: ijms24076535
doi: 10.3390/ijms24076535
pmc: PMC10095405
pii:
doi:

Substances chimiques

Chlorine 4R7X1O2820

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NRRP
ID : 0001052

Références

PLoS One. 2014 Sep 26;9(9):e108598
pubmed: 25259528
Viruses. 2021 Nov 04;13(11):
pubmed: 34835033
World J Microbiol Biotechnol. 2016 Apr;32(4):70
pubmed: 26941243
Appl Environ Microbiol. 2009 Jan;75(1):93-100
pubmed: 19011076
Viruses. 2018 Apr 19;10(4):
pubmed: 29671810
Infect Drug Resist. 2022 Mar 30;15:1399-1410
pubmed: 35386291
Nat Rev Microbiol. 2018 Nov;16(11):661-670
pubmed: 30127345
Antimicrob Resist Infect Control. 2014 Nov 26;3:34
pubmed: 25937922
Adv Exp Med Biol. 2019;1214:79-91
pubmed: 31321750
J Environ Health Sci Eng. 2022 Feb 7;20(1):219-225
pubmed: 35669812
BMC Microbiol. 2013 Jul 08;13:154
pubmed: 23834712
Environ Res. 2020 Sep;188:109916
pubmed: 32846656
Environ Sci Technol. 2017 Jul 18;51(14):7759-7774
pubmed: 28677960
Infect Drug Resist. 2019 Feb 27;12:501-510
pubmed: 30881055
Front Microbiol. 2019 Jan 22;10:12
pubmed: 30723460
Pathogens. 2020 Jun 23;9(6):
pubmed: 32585922
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa049
pubmed: 34192248
Ecotoxicol Environ Saf. 2022 May 1;236:113476
pubmed: 35367880
J Infect Prev. 2019 Mar;20(2):76-82
pubmed: 30944591
J Food Prot. 2018 Oct;81(10):1673-1678
pubmed: 30222002
Front Microbiol. 2016 Jun 08;7:825
pubmed: 27375566
Bull Environ Contam Toxicol. 2021 Apr;106(4):560-567
pubmed: 33629148
Curr Res Toxicol. 2021;2:159-168
pubmed: 33688633
Nat Commun. 2019 Feb 27;10(1):968
pubmed: 30814504
Microb Biotechnol. 2019 Jul;12(4):742-751
pubmed: 31025530
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
PLoS One. 2015 Jul 01;10(7):e0131714
pubmed: 26131892
Microorganisms. 2021 Jan 27;9(2):
pubmed: 33513949
PLoS One. 2018 Jul 12;13(7):e0199616
pubmed: 30001345
PLoS One. 2016 Feb 17;11(2):e0148857
pubmed: 26886448
Microbiome. 2023 Mar 30;11(1):64
pubmed: 36991513
Lancet. 2011 Jan 15;377(9761):228-41
pubmed: 21146207
Emerg Infect Dis. 2018 Sep;24(9):1752-1753
pubmed: 30124425
Microorganisms. 2022 Jan 20;10(2):
pubmed: 35208679
Front Environ Sci Eng. 2021;15(4):65
pubmed: 33145119
Front Microbiol. 2021 Jul 21;12:707330
pubmed: 34367112
Appl Environ Microbiol. 2003 Aug;69(8):5032-6
pubmed: 12902308
Res Microbiol. 2002 Jan-Feb;153(1):13-8
pubmed: 11881893
Antibiotics (Basel). 2021 Dec 29;11(1):
pubmed: 35052912
Int J Environ Res Public Health. 2021 Aug 27;18(17):
pubmed: 34501634
Vet Microbiol. 2016 Aug 15;191:65-71
pubmed: 27374909
Antibiotics (Basel). 2018 Dec 14;7(4):
pubmed: 30558235
Food Environ Virol. 2022 Mar;14(1):1-9
pubmed: 34773567
Annu Rev Food Sci Technol. 2019 Mar 25;10:151-172
pubmed: 30633564
Int J Mol Sci. 2019 Mar 27;20(7):
pubmed: 30934725
Infect Drug Resist. 2018 Jul 30;11:1015-1026
pubmed: 30104889

Auteurs

Maria D'Accolti (M)

Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTA, University of Ferrara, 44121 Ferrara, Italy.
CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Irene Soffritti (I)

Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTA, University of Ferrara, 44121 Ferrara, Italy.
CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Francesca Bini (F)

Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTA, University of Ferrara, 44121 Ferrara, Italy.
CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Eleonora Mazziga (E)

Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTA, University of Ferrara, 44121 Ferrara, Italy.
CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Luca Arnoldo (L)

Department of Medicine, University of Udine, 33100 Udine, Italy.

Antonella Volta (A)

CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Matteo Bisi (M)

CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Paola Antonioli (P)

Department of Infection Prevention Control and Risk Management, S. Anna University Hospital, 44124 Ferrara, Italy.

Patrizia Laurenti (P)

Department of Health Sciences and Public Health, Section of Hygiene, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Walter Ricciardi (W)

Department of Health Sciences and Public Health, Section of Hygiene, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Sara Vincenti (S)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Sante Mazzacane (S)

CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Elisabetta Caselli (E)

Section of Microbiology, Department of Chemical, Pharmaceutical and Agricultural Sciences, and LTTA, University of Ferrara, 44121 Ferrara, Italy.
CIAS Research Center, University of Ferrara, 44122 Ferrara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH